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JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITYABSTRACT
The Aryl Hydrocarbon Receptor (AhR) is required for the toxicity of TCDD, and so the AhR of 
CRL:WI and CRL:WI(Han) rats was characterised. Western blot showed AhR proteins of ~110 
and ~97 kDa in individual rats from both strains. The AhR cDNA from a CRL:WI(Han) rat with 
the ~110kDa protein revealed a sequence that was identical to that of the CRL:WI and SD rat. 
However, cloning of the AhR from a rat with the ~97kDa protein revealed a point mutation, and 
five variants encoding two C-terminally truncated variants of the AhR protein, arising from a 
point mutation in the intron/exon junction and consequent differential splicing. These C-termi-
nally truncated variants were expressed and shown to give rise to a protein of ~97kDa; the re-
combinant AhR bound TCDD with an affinity that was not statistically different from the full-
length protein. A single-nucleotide polymorphism (SNP) assay was developed, and showed that 
both alleles were represented in a Hardy-Weinberg equilibrium in samples of CRL:WI and 
CRL:WI(Han) populations; both alleles are abundant. Rats from two studies of TCDD develop-
mental toxicity were genotyped, and the association with toxicity investigated using statistical 
analysis. There was no plausible evidence that the AhR allele had a significant effect on the tox-
ic endpoints examined. These data show that the two AhR alleles are common in two strains of 
Wistar rat, and that the AhR alleles had no effect on TCDD-induced developmental toxicity in 
two independent studies. 
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2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a ubiquitous toxin, and a prototypical represent-
ative of a series of chemicals which effect toxicity through a common mechanism, binding to 
the Aryl Hydrocarbon Receptor (AhR) (Poland et al., 1976a) (Poland and Knutson, 1982). Re-
search has focussed on the toxicity of TCDD, on the basis that other chemical congeners will 
show the same toxicity as TCDD, but will merely have different potency (Van den Berg et al., 
2006). Mouse genetic studies demonstrated that dioxin toxicity is mediated through the AhR lo-
cus (Poland and Knutson, 1982). The subsequent cloning of the AhR (Burbach et al., 1992) 
(Ema et al., 1992) characterised the AhR as a transcription factor. The creation of AhR knockout 
mice enabled the confirmation that AhR was required for dioxin toxicity (Fernandezsalguero et 
al., 1995) (FernandezSalguero et al., 1996) (Schmidt et al., 1996) (Shimizu et al., 2000), and 
specific alterations in the AhR control dioxin-mediated toxicity (Walisser et al., 2004) (Bunger 
et al., 2003).
Maternal dosing with low doses of TCDD during pregnancy is reported to cause adverse effects 
in the reproductive system of male offspring, notably decreased sperm count in the cauda epidi-
dymis of Holtzmann (Mably et al., 1992) or Wistar (Faqi et al., 1998) rats. These effects were 
used to set a Tolerable Daily Intake of 2pg kg-1 day-1 for TCDD and related compounds by the 
UK Committee on Toxicity (Committee on Toxicity, 2001). Subsequent studies have failed to 
reproduce these effects in Holtzmann rats (Ikeda et al., 2005) (Ohsako et al., 2001). We under-
took studies in the Wistar(Han) rat (CRL:WI(Han)), and showed that TCDD did not cause po-
tent developmental effects on offspring sperm levels at postnatal day 120 (Bell et al., 2007a) 
(Bell et al., 2007b) (Bell et al., 2007c). During the course of these studies, it became clear that 
there was a size polymorphism in the AhR of the CRL:WI(Han) rat (MQF, DRB, unpublished 
data). There was therefore a concern that the size polymorphism of the AhR protein might re-
flect a different AhR allele, and that the different AhR alleles might control TCDD toxicity in 
this system.
The Wistar(Han) (Kuopio) rat is resistant to specific toxic effects of TCDD (Pohjanvirta and 
Tuomisto, 1994) (Pohjanvirta et al., 1987), and one allele for resistance to the acute lethality of 
TCDD in a Long-Evans x Wistar(Han) cross was subsequently shown to co-segregate with an 
AhR allele (Pohjanvirta, 1990) (Tuomisto et al., 1999), suggesting that the AhR allele was re-
sponsible for the phenotype. The polymorphism in the Wistar(Han) (Kuopio) AhR has been 
characterised (Moffat et al., 2007) (Pohjanvirta et al., 1998). However, it was discovered that 26/11/08 Page 3
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tar(Han) rats  (derived from Zentralinstitut für Versuchstierzucht GmbH, Hannover, FRG). The 
inbred Long-Evans rats had significantly different susceptibility to the acute lethality of TCDD 
compared with outbred Long-Evans rats, and the small Finnish colony of Wistar(Han) rats had 
different susceptibility to the acute lethality of TCDD, compared to a different batch of Wis-
tar(Han) rats (Pohjanvirta and Tuomisto, 1990), and hence the Finnish rats were named as the 
inbred L-E (Turku/AB) and outbred H/W (Kuopio) strains. It is therefore not clear to what ex-
tent the characteristics of the Kuopio strain of Wistar(Han) rats are representative for other Wis-
tar(Han), or Wistar, strain rats. Given that the AhRhw allele confers ~100-fold resistance to the 
acute lethality of TCDD in adults, there was the possibility that this AhR allele might be present, 
and have affected the developmental toxicity of TCDD in our study in Wistar(Han) rats.
Given that AhR polymorphisms are known to be determinative of TCDD-induced toxicity in 
the mouse, we therefore sought to investigate the AhR of the CRL:WI(Han) rat, whether there 
were any genetic polymorphisms in AhR, and characterising what those polymorphisms were. 
Any polymorphisms might have affected the toxicity of TCDD in our studies with this rat strain 
(Bell et al., 2007a) (Bell et al., 2007b) (Bell et al., 2007c), and so we investigated whether pol-
ymorphic AhR variants have altered affinity for TCDD, and whether these polymorphisms in 
the AhR of the CRL:WI(Han) rat are associated with susceptibility to the developmental toxic-
ity of TCDD in two separate studies.26/11/08 Page 4
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All chemicals were of the highest quality available. Rats of three strains: Wistar (CRL:WI), 
Wistar (Han) (CRL:WI(Han)) and  Sprague-Dawley (CRL:CD(SD)) were all from Charles Riv-
er Laboratories, UK. Samples of CRL:WI(Han) liver were obtained from previously described 
studies on the developmental toxicity of TCDD (Bell et al., 2007b) (Bell et al., 2007c); samples 
from these studies which were analysed for RNA levels (Bell et al., 2007a) were selected for 
genotyping.
Western blotting. Rats were killed by barbiturate overdose and the liver perfused with ice-cold 
MDEG buffer (25mM MOPS, pH 7.5, 1mM DTT, 1mM EDTA, 10% glycerol). The liver was 
flash frozen in liquid nitrogen and stored at -80ºC for later use. An aliquot of frozen liver was 
homogenized with 6 volumes of MDEG buffer containing 20mM sodium molybdate. Cytosol 
was prepared by an initial centrifugation at 10,000g for 10 minutes, and the resulting superna-
tant was centrifuged again at 240,000g for 30 minutes. The cytosol was collected and protein 
concentration was determined by a Bradford Assay using BSA as a reference. Protein (60μg/
lane) was separated on a polyacrylamide gel electrophoresis (PAGE) (either SDS-PAGE, or 
pre-cast gels (Invitrogen) using lithium duodecyl sulphate) and transferred to a PVDF mem-
brane (Immobilon, USA). Signal was detected using Enhanced Chemiluminescence (ECL; GE 
Healthcare) and exposed to a film. The antibody against AhR has been previously described 
(Fan et al., 2008).
Cloning of CRL:WI(Han) AhR. Livers from CRL:WI(Han) rats expressing either the lower 
or higher Mr AhR were selected for gene cloning. Total RNA was extracted from frozen rat liver 
tissue using Trizol reagent, and PolyA+ mRNA was isolated from total RNA using Oligotex Di-
rect mRNA Kits (Qiagen) according to manufacturers' protocol. Reverse transcription was per-
formed with Enhanced Avian RT First Strand Synthesis Kit using oligo (dT)23 as primer. The 
full length coding region of the AhR was obtained in three fragments (Fragments1-3) using PCR 
primers based on the sequence for CRL:WI rat AhR; the primers are shown in Table 1. Jump-
Start AccuTaq LA DNA Polymerase Mix (Sigma) was used for PCR and the products were sub-
cloned into pGEM-T plasmids (Promega). The inserts were verified by double stranded DNA 
sequencing. Three fragments of each variant previously separately cloned in pGEM-T plasmids  
were used to produce full length AhR by restriction digest with appropriate enzyme and ligation. 
In order to facilitate in vitro expression of the AhR variants, a Kozak consensus sequence was 
introduced into 5'-end of the full length AhR by PCR with primers NOTKFW and APARV 26/11/08 Page 5
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ro expression of the AhR proteins in TNT® Coupled Reticulocyte Lysate System (Promega) in 
the presence of [35S]-methionine. The expressed proteins were separated on 8% SDS PAGE.  
The gel was dried and exposed to a film or phosphor imaged.
Plasmid construction.  Methods were essentially as described (Fan et al., 2008). Full length rat 
AhR variants (Wild-type, Deletion and Insertion) were cloned into pGEM-T Easy. A His6 tag 
was introduced at the C-terminus by PCR with forward primer rBam-5 (AhR  bases 1226-1252) 
and backward primers rHis-3-Del or rHis-3-Ins (Table 2). Fragments were gel-purified, and 
cloned into plasmid pGEM-T Easy (Promega), and checked by double strand sequencing. There 
was a single mutation (A2336G) in rAhR deletion variant sequence, and  site-directed mutagen-
esis was used to change this mutation. QuikChange Site-Directed mutagenesis kit was pur-
chased from Stratagene  (USA), and mutagenesis was performed according to the manual. The 
plasmids pGEM-T Easy containing rAhR variants fragments with His6 tag were double-digest-
ed with BamHI and Hind III, and then the target fragments (about 1200bps) were used to replace 
the wild type rAhR sequence between BamHI and Hind III sites in the plasmid 
pFastBac1.rAhR.His, which was constructed previously. The rAhR variants and His6 sequenc-
es were confirmed by DNA sequencing. Bac-to-Bac (Invitrogen) system was used to express 
recombinat AhRs in insect cells. Plasmids pFastBac1.rAhR-deletion.His and pFastBac1.rAhR-
insertion.His were transformed into the bacterial strain DH10Bac (Invitrogen), and bacmids 
prepared by Qiagen miniprep column. The presence of AhR inserts was confirmed by PCR.
The bacmids were then transfected into Sf9 cells, baculovirus was harvested after 5-7 days in-
cubation and then further amplified in infect Sf9 cells to obtain high titre virus. Virus was di-
rectly titred in a plate assay, and high titre virus stocks were used to infect Sf9 cells and express 
recombinant AhRs. Virus was added to Sf9 cell culture, and infected Sf9 cells were harvested 
by centrifugation at 500g for 10 minutes at 48 hours after infection, or as indicated, and all sub-
sequent steps were on ice or at 4°C. Cell pellets were re-suspended in MDEG buffer (25mM 
MOPS, 1mM DTT, 1mM EDTA, 10% glycerol, pH7.5) containing 20mM molybdate. Cells 
were broken by sonication, and cell debris was removed by centrifugation at 12,000g for 10 
minutes. The supernatant was further centrifuged at 200,000g for 30 minutes. The final cytosol-
ic supernatants were divided into small aliquots and stored at -80°C. 26/11/08 Page 6
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by (Poland et al., 1976a), as amended by (Fan et al., 2008) for expression of AhR using bacu-
lovirus.  Typically, rat liver cytosol was diluted to 5mg/ml in MDEG buffer (25mM MOPS, 
1mM DTT, 1mM EDTA, 10% glycerol, pH7.5) containing 20mM molybdate. Then the sample 
was incubated with [3H]-TCDD or [3H]-TCDD plus a 200-fold excess of competitor TCAOB 
(Poland et al., 1976b) at 4°C overnight. After incubation, 30μl of dextran-coated charcoal sus-
pension (67mg/ml, prepared in MDEG buffer) was added into a 200μl sample of the mixture. 
The suspension was incubated on ice for 10min, and then was centrifuged at 25,000g for 10min. 
150μl of the supernatant was removed and radioactivity was measured in a scintillation counter. 
Specific binding was defined as the difference of radioactivity between without (total binding) 
and with competitor TCAOB (non-specific binding). For recombinant rat AhR protein, either 
0.25mg or 0.5mg/ml cytosol protein was used for binding assay, and supplemented with BSA 
to a final protein concentration of 5mg/ml. Specific saturable binding (Kd) was characterised by 
using non-linear regression, using Graphpad 4/5, fitting a saturation binding isotherm.
SNP detection in genomic DNA. Genomic DNA was extracted from 20-25mg of frozen tissue 
with 0.6ml of lysis buffer (10mM Tris-HCl, pH 7.5; 400mM NaCl; 100mM EDTA; 0.6% SDS) 
containing 0.35mg of proteinase K. The sample was incubated at 60°C for 16 hours, to which 
0.2ml of 5M NaCl was added at the end of the incubation, and centrifuged for 10 minutes at 
10000g. The DNA containing supernatant was collected and precipitated by adding equal vol-
ume of ice cold 90% ethanol followed by centrifugation. The resulting DNA pellet was washed 
with cold 75% ethanol and air dried. The DNA pellet was then resuspended in 100μl water. 
DNA concentration was determined by measurement of a fluorescent dsDNA binding probe, Pi-
coGreen (Molecular Probes) according to the manufacturer's instructions, using a λ DNA for 
the standard curve. The fluorescence in each well was measured using a plate reader (Victor, 
Fenland) setting at excitation 485 nm and emission 510 nm. Duplex real-time PCR was per-
formed using Brilliant Multiplex QPCR Master Mix (Stratagene) according to the manufactur-
er's protocol with slight modification. PCRs were set up in a total volume of 20μl of buffer 
solution containing the following: 10 μl of 2x master mix; 300nM of each of both molecular 
beacons; 300nM of each primer (SNP66 and SNP150) and 40ng of genomic DNA. A Stratagene 
MX3000p cycler was used for PCR: 10 min at 95°C followed by 40 cycles of 95°C for 20 s, 
52°C for 1 min, and 72°C for 30 s. The fluorescence of the molecular beacons was measured 
during the annealing step of the PCR cycle. The cycle number at which the signal was above the 
threshold fluorescence (Ct) was determined using Stratagene software. Negative controls (no 26/11/08 Page 7
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analysis.
Statistical methods. Kd values for the affinity of AhR for TCDD were compared using a t-test. 
Observed genotype frequencies were compared with expected allele frequencies, including 
those expected under Hardy-Weinberg equilibrium, using a Pearson χ2 statistic. Previous anal-
yses of body and organ weights and measures of reproductive toxicity in acute and chronic dos-
ing experiments (Bell et al., 2007b) (Bell et al., 2007c) examined dose-response relationships 
by ANOVA methods, including mixed models with random effects terms for litter effects. 
These responses were reanalysed, for those animals and tissues for which genotyping had been 
carried out, under the same models but with an additional factor representing the genotype as 
wild type, mutant or heterozygous.  Interest was specifically in whether the different types had 
different susceptibility to the effects of TCDD, and this was examined by fitting interaction 
terms between TCDD dose and genotype. The data set from the animal studies, together with 
the genotyping and RNA data, is provided in Supplementary data as an Access database.26/11/08 Page 8
JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITYRESULTS
Whilst preparing cytosol for analysis of ligand-binding to [3H]-TCDD from CRL:WI(Han) rats, 
it was noted that there were multiple size variants of the AhR immunodetected in Western blots, 
with protein sizes of ~110 and ~97 kDa (Fig. 1A). These size variants were reproducible in cy-
tosol preparations from an individual rat; moreover, the banding pattern was unchanged by the 
inclusion of protease inhibitors during cytosol preparation, or to optimisation of the denaturing 
conditions for SDS-PAGE (Data not shown). Cytosol from Sprague-Dawley rat liver (Fig. 1A) 
(and C57Bl/6 and DBA/2J mouse liver, (data not shown)) consistently produced an AhR protein 
of the expected size, suggesting that the different protein bands were not a product of proteoly-
sis, but were intrinsically different AhR forms. The phenomenon is not restricted to the 
CRL:WI(Han) rat, since the CRL:WI rat also shows two AhR size variants in hepatic cytosol 
(Fig. 1B).
Cloning of variant AhR cDNAs from CRL:WI(Han) rat
To determine if the differently-sized AhR protein variants were the result of different mRNA 
sequences, AhR cDNAs were cloned from CRL:WI(Han) rats that were known to have either a 
110 kDa or 97 kDa protein product. Double-stranded sequencing of AhR clones from rats with 
the 110 kDa AhR protein revealed that the sequence was identical to that of the CRL:WI 
(AJ821851) and Sprague-Dawley  rat (AAA56897), yielding a protein of 853 amino acids (Ac-
cession number AM902286). This AhR sequence is hereinafter referred to as the wild-type se-
quence. However, there were five variants in the AhR clones from the rat with the 97 kDa AhR 
protein, as shown in Fig. 2; at least two independent cDNAs of each variant were sequenced. 
These have a common Val497Ala point mutation, and the multiple cDNA variants are consist-
ent with a point mutation at the end of exon 10 of the AhR, causing the use of alternative splicing 
sites (Pohjanvirta et al., 1998); accordingly, the nomenclature of Pohjanvirta et al. is used here-
in, and the AhR sequence encoding the 97 kDa protein is designated the mutant allele. The “De-
letion” variant loses 129 bases from the end of exon 10, yielding a protein of 810 amino acids 
(AM902281). The “Insertion” variants use alternative splice sites with an extra 29, 126, 129 or 
134 bases from the intron between exons 10 and 11, resulting in a protein of 815 amino acids 
(AM902282-AM902285). This evidence shows that the differently sized AhR proteins in 
CRL:WI(Han) rats arise from different cDNAs.26/11/08 Page 9
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The recombinant cDNAs were cloned and expressed in reticulocyte lysates to determine their 
size, and whether the Insertion and Deletion variants were viably translated, and could be dis-
tinguished on SDS-PAGE. Fig. 3A shows that both the Insertion and Deletion cDNAs produced 
a protein of the expected size, but that these could not be distinguished from one another on 
SDS-PAGE. By contrast, the wild-type protein migrated more slowly than the variant alleles. 
To confirm this, the proteins were then expressed using the baculovirus expression system, and 
cytosolic extracts prepared and analysed by western blotting with an AhR specific antibody. 
Fig. 3B shows that uninfected Sf9 cells show no immunoreactive bands, confirming the specif-
icity of the antibody. The Wild-type AhR shows a band of ~110 kDa, and the Insertion and De-
letion variants show bands at ~100 kDa, which are of a similar size to each other. These findings 
show that both the Insertion and Deletion AhR variants are capable of giving rise to a protein 
product that can migrate faster than the wild-type AhR, and provides strong evidence that the 
faster-migrating AhR protein variant in Fig. 1 arise from both the Insertion and Deletion forms 
of the variant AhR in CRL:WI(Han) and CRL:WI rats.
To test if there was any difference in ligand-binding functionality of the AhR alleles, a previ-
ously validated baculovirus expression system for AhR was used (Fan et al., 2008). The AhR 
proteins expressed in baculovirus were assayed for the ability to bind TCDD as a ligand (Fig. 4). 
The ligand-binding assay showed saturable and specific binding, and gave values for rat liver 
cytosol which are consistent with the literature (data not shown). Although the maximal amount 
of specific binding (Bmax) varied between batches by two-three fold, the affinity of the ex-
pressed AhR proteins for [3H]-TCDD was not significantly different. For multiple independent 
saturation binding assays, the dissociation constants (Kd) were: wild-type, 1.34 ± 0.32 nM (n=6 
independent determinations, mean ± Standard Deviation); Insertion, 1.07±0.47 nM (n=3); De-
letion 1.22±0.72 nM (n=3). Thus there were no significant differences in the ligand-binding af-
finity for TCDD between the variant AhRs of CRL:WI(Han) rat.
An SNP assay for AhR alleles
In order to be able to determine if the AhR alleles were able to affect susceptibility to toxic end-
points in our studies (Bell, et al., 2007a;  Bell, et al., 2007b;  Bell, et al., 2007c), it was necessary 
to develop an SNP assay to discriminate between alleles. Molecular beacon technology (Marras 
et al., 1999) was used to probe the allelic variant at the exon 10 junction, in a 108bp amplicon. 26/11/08 Page 10
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(A) allele at the 1st nucleotide of intron 10 in the rat AhR (Table 1); note that this assay does 
not differentiate between the Insertion and Deletion transcripts, which are produced as a result 
of post-transcriptional processing. Initial hybridisation studies with the probes showed discrim-
ination between wild-type and mutant allele oligonucleotides, with strong signal to the match-
ing probe, minimum signal from the mismatched oligonucleotide, and hence maximum 
discrimination at 52°C (data not shown). The optimised PCR reaction (Fig. 5A-C) shows that 
both probes can be used in the same PCR reaction to yield unambiguous discrimination between 
wild-type and mutant alleles in genomic DNA. There was clear discrimination between wild-
type, mutant and heterozygote DNA samples when using large numbers of samples (Fig. 5D), 
and hence this assay was validated to analyse the tissue samples available from our previous in 
vivo studies.
Analysis of the populations from the acute and chronic studies was divided up into the maternal 
and offspring, since the offspring represent a dependent population (Table 2). Neither of the 
acute study populations, nor the chronic parents, show a significant variation from a 1:2:1 ratio 
of genotypes (χ2=4, 0.44 and 3.7, respectively). By contrast, the offspring in the chronic study 
had a ratio that was significantly different  (χ2=19, P<0.001) from the expected 1:2:1 ratio, with 
over-representation of the homozygous wild-type allele; this presumably reflects the genotype 
of the relatively small number of parents. A sample of thirty non-sibling CRL:WI(Han) rats in 
2007 failed to show any significant deviation from the expected 1:2:1 ratio (χ2=1.1). Thus it ap-
pears that the wild-type and mutant AhR alleles are equally represented in CRL:WI(Han) rats. 
A sampling of 51 CRL:WI rats, of unknown inter-relationships, found that there was a signifi-
cant deviation from the expected 1:2:1 genotype ratio (χ2=25)(Table 2). However, the genotype 
frequencies in this population did not deviate significantly from a Hardy-Weinberg equilibrium 
(χ2=2.9), and thus there is no evidence for systematic skewed representation of the homozygous 
AhR alleles in the CRL:WI rat.
Association between AhR genotype and toxicity
In the analysis of phenotypic endpoints in the acute (Bell et al., 2007b) and chronic (Bell et al., 
2007c) studies on TCDD developmental toxicity, with a view to determining if the toxicity in 
these studies was affected by genotype at the AhR locus, there was a prior expectation that any 
biologically relevant interaction between treatment and genotype would show a similar size and 
direction of effect between the acute and chronic studies, and would show an appropriate dose-26/11/08 Page 11
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tistical analyses are provided as a Table for each endpoint  (Supplementary Material). The prin-
cipal toxic effects seen in those studies were reduction in body weight gain in the F1 animals, 
delay in balano-preputial separation, and total litter loss in the offspring. It was not possible to 
assay the animals which had died as a result of total litter loss, since no samples of the dead an-
imals were taken, but the other measures of toxicity were examined. Maternal cytochrome P450 
1A1 (CYP1A1) RNA levels (Bell et al., 2007a) showed no significant correlation with genotype 
in either the acute or chronic study. In the offspring, CYP1A1 RNA levels at PND70 showed 
no correlation with genotype in the chronic study, but there was a significant association 
(P~0.019) between genotypes in the acute study, with heterozygous animals having 1.7-fold, 
and homozygous mutant animals having 2.5-fold the level of CYP1A1 RNA as homozygous 
wild-type animals. Given the relatively low levels of CYP1A1 RNA in rats at PND70, the fact 
that the mutant appears more responsive than wild-type, the small size of the effect, and the lack 
of effect in the chronic study, or the mothers, it is likely that this association is due to chance. 
Balano-preputial separation was found to be significantly delayed by TCDD treatment in both 
studies (Bell, et al., 2007b;  Bell, et al., 2007c), but there was no significant association between 
genotype and day of balano-preputial separation. Liver: body weight ratio is also a classical 
marker of TCDD toxicity and AhR function (Bunger, et al., 2003;  Schmidt, et al., 1996), but 
rat genotype showed no significant association with liver: body weight ratio. There was a sta-
tistically significant association between genotype and spleen: body weight ratio in the chronic 
study at PND 70, but not PND120, but there was no interaction with dose, nor an effect on 
spleen: body weight ratio in the acute study at any age (Supplementary Material).
F1 offspring were identified individually from PND21 onwards, and body weights after this 
time were affected by TCDD treatment of the dams. There was a statistically significant asso-
ciation between genotype and body weight in the chronic (P~0.015), but not the acute, study. 
However, a plot of the difference in weight between homozygous wild-type and mutant alleles 
by dose group, revealed no biologically plausible, or consistent, response (see Supplementary 
Tables, and Supplementary Figures 1 and 2). With the body weight data set, there was a signif-
icant association between post-natal day and genotype for the chronic study (but not the acute), 
and for group and genotype for the acute study (but not the chronic study), and a significant as-
sociation between post-natal day, group and genotype for both studies. However, a plot of the 
data did not show any consistent or plausible effect of genotype on body weight. Thus there was 26/11/08 Page 12
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which could plausibly reveal a biological effect of the genotype.26/11/08 Page 13
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We discovered that the Wistar strain rats used in our previous studies (Bell et al., 2007a) (Bell 
et al., 2007b) (Bell et al., 2007c) had two size variants of the AhR protein present in liver cy-
tosol, and have shown that the size variants are the result of a genetic polymorphism of the AhR 
present in CRL:WI and CRL:WI(Han) rats (Fig. 1, Fig. 2). The discovery of this genetic poly-
morphism in the AhR raised the possibility that it could be determinative of the function of the 
AhR, as is known for the AhRb/d polymorphisms in the mouse (Poland et al., 1994). The murine 
AhR polymorphisms are known to affect the affinity of the AhR protein for the ligand, TCDD 
(Harper et al., 1988) (Poland et al., 1994), and since the binding of ligand to the receptor is a 
rate-limiting step for the function of the receptor, a change in the affinity of the AhR for ligand 
would inevitably impact upon the function of the receptor. In order to test this possibility, we 
undertook recombinant expression of the  variant AhR proteins produced. Both deduced protein 
sequences gave rise to a protein product (Fig. 3), and they were both shown to encode a func-
tional ligand-binding AhR, with affinity for TCDD that was statistically indistinguishable from 
the affinity of the wild-type AhR (Fig. 4). This extends the finding that the affinity for TCDD 
(Kd) of cytosol from Long-Evans (Turku AB) and Wistar(Han) (H/W(Kuopio)) rats was similar 
(Pohjanvirta et al., 1999). The ligand-binding domain of the AhR resides in a minimal domain 
of amino acids 228-416 (Bell and Poland, 2000) (Coumailleau et al., 1995) (Poland et al., 1994); 
since the polymorphisms in the rat AhR are at amino acid 497, and at the C-terminus (the trans-
activation domain), our data confirms that the sites of allelic variation are outside the domain 
responsible for ligand-binding.
Western blotting shows that both AhR alleles are present in the CRL:WI and WI(Han) stock, 
but the allele frequency in Wistar strain rats was unknown. Molecular beacon technology (Mar-
ras et al., 1999) was developed for a robust and rapid SNP assay (Fig. 5). This methodology en-
abled the determination that both alleles were present in both CRL:WI, and CRL:WI(Han) rats, 
at ratios that were not divergent from the Hardy Weinberg equilibrium; thus there is no evidence 
for systematic under-representation of the homozygous mutant allele, for example. Given the 
severe physiological consequences of a null AhR allele in mouse (Bunger et al., 2003) (Fernan-
dezsalguero et al., 1995) (Schmidt et al., 1996) (Walisser et al., 2004), it is a reasonable hypoth-
esis that rats with a homozygous mutant of the AhR would show pathology if the AhR allele 
characterised herein were hypomorphic or functionally null. The absence of under-representa-26/11/08 Page 14
JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITYtion of the AhR null allele homozgyotes argues against the mutant alleles being functionally null 
or hypomorphic.
Faqi et al. found developmental toxicity of TCDD in Wistar rats (Bor: spf, TNO) (Faqi et al., 
1998), and we undertook our studies (Bell et al., 2007a) (Bell et al., 2007b) (Bell et al., 2007c) 
in the CRL:WI(Han) rat since (a) it was not possible to use the Wistar strain used by Faqi (b) 
there was extensive background information on the CRL:WI(Han) strain in house (c) the Wis-
tar(Han) strain is derived from the Wistar strain. Although Table 2 shows the chronic study F1 
rats had a significant difference from the equilibrium 1:2:1 AhR genotype, this was not true for 
the chronic P0 dams, or in the acute study. Thus both alleles are prevalent in CRL:WI and 
CRL:WI(Han) populations, and these findings are likely to be informative for many Wistar col-
onies. However, it is important to note that inappropriate breeding strategies or chance may re-
sult in the exclusion of one of the AhR alleles from an individual Wistar colony. Studies in 
Wistar strain rats on the toxicity of TCDD, or similarly acting compounds, may be affected by 
the presence of allelic variants of the AhR (Banudevi et al., 2006) (Taketoh et al., 2007).
Toxicity endpoints from data in (Bell et al., 2007a) (Bell et al., 2007b) (Bell et al., 2007c) were 
correlated with rat genotype (Table 2). In view of the known pitfalls of undertaking multiple sta-
tistical tests (Ioannidis, 2005) (Ioannidis et al., 2001), the analysis was restricted to a discrete 
series of endpoints that were set out in advance. The AhR alleles did not have a significant as-
sociation with liver: body weight ratio, and this suggests that the variant rat allele is sufficiently 
functional to support the normal vascularisation of the liver (Schmidt et al., 1996) (Walisser et 
al., 2004). There was no plausible association of AhR allele on induction of cytochrome P450 
1A1 RNA, or between AhR allele and body weight or balano-preputial separation, the two most 
sensitive markers of TCDD-induced toxicity in the developmental studies (Bell et al., 2007c). 
The absence of any plausible and statistically signficant association between AhR genotype and 
toxicity endpoints makes a compelling case that there was no causal effect of the AhR allele on 
the toxicity of TCDD resulting from developmental exposure of male pups (Bell et al., 2007a) 
(Bell et al., 2007b) (Bell et al., 2007c). Therefore the conclusions derived from the studies of 
TCDD developmental toxicity do not require reinterpretation to accomodate the effect of AhR 
genotype, as there was no evidence to support an effect of AhR genotype on TCDD develop-
mental toxicity (Bell, et al., 2007a;  Bell, et al., 2007b;  Bell, et al., 2007c).26/11/08 Page 15
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pressed body weight) after a single maternal dose of 1 μg kg-1 (Bell et al., 2007b) or 46 ng kg-
1 day-1 (Bell et al., 2007c) in CRL:WI(Han) rats; which is exquisitely sensitive in comparison 
to the acute lethality at >10,000 μg TCDD kg-1 in adult rats with the AhRhw allele (Tuomisto et 
al., 1999). It is startling that the AhRhw allele can confer such marked resistance to lethality of 
TCDD in adults, yet have no effect on the much more sensitive endpoint of developmental tox-
icity (this study). A particular strength of the approach in this study is that all of the animals 
shared the common genetic background of the CRL:WI(Han) rat, and this contrasts with the A, 
B and C lines of (Tuomisto et al., 1999), which are descended from a cross between an inbred 
Long-Evans and Han/Wistar(Kuopio) rats. Although the Ahrhw and “B” genes have been shown 
to segregate with susceptibility to the acute lethality of TCDD in the Long-Evans x Han/Wis-
tar(Kuopio) cross of (Tuomisto et al., 1999), it is clear that these genes do not determine sus-
ceptibility to all other toxicities arising from TCDD exposure (Pohjanvirta and Tuomisto, 
1994). Consequently, it is entirely possible that other genetic loci could be determinative for 
particular TCDD-induced toxicities, and that they could differ between the parental  L-E 
(Turku/AB) and H/W (Kuopio) strains, and in the derived lines. There is evidence for differen-
tial developmental toxicity of TCDD between the two parental lines (Huuskonen et al., 1994), 
and thus any differential response of the A-C lines to developmental toxicity does not necessar-
ily demonstrate a role for the Ahrhw or “B” genes (Simanainen et al., 2004). This study therefore 
provides clear evidence from a study in the common genetic background of the CRL:WI(Han) 
rat that the wild-type and mutant AhR alleles did not measurably affect multiple parameters of 
TCDD-induced developmental toxicity in two separate studies (Bell et al., 2007a) (Bell et al., 
2007b) (Bell et al., 2007c). The disparity in the data on genetic linkage between susceptibility 
to TCDD-induced developmental toxicity or acute lethality makes a compelling case for using 
definitive transgenic approaches to determining whether the AhRhw confers resistance to 
TCDD-induced lethality.
In summary, there is an allelic form of the AhR which is common in CRL:WI(Han) and 
CRL:WI rats, and the allele results in alternative splicing and C-terminal truncation, together 
with an amino acid mutation, in the AhR. The variant allele yields two C-terminally truncated 
proteins, but does not affect the affinity of AhR for the ligand, TCDD. The allele does not show 
a plausible association with endpoints of TCDD-induced developmental toxicity in two inde-
pendent studies, and our data therefore shows that this AhR allele did not affect TCDD-induced 
developmental toxicity in our previous studies (Bell et al., 2007a) (Bell et al., 2007b) (Bell et 26/11/08 Page 16
JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITYal., 2007c). Genetic linkage data show a marked difference in the association of AhRhw on sus-
ceptibility with TCDD-induced acute lethality, or developmental toxicity, and this study calls 
into question whether the reported association with AhRhw is an effect of a linked gene, or the 
AhRhw allele.26/11/08 Page 17
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FIG. 1. AhR size variants in Wistar strain rats. A, 60 μg of hepatic cytosolic protein, pre-
pared as described in materials and methods, from three CRL:WI(Han) rats (WI(Han)) and a 
Sprague-Dawley rat (SD) were electrophoresed on SDS-PAGE, and immunodetected with an 
antibody specific for the AhR LBD. Visualisation was with ECL. The size of molecular weight 
markers is shown in kDa (Mr, Kda). B, as for A but with CRL:WI rats (Wistar). 
FIG. 2. Cartoon of cloned AhR variants from CRL:WI(Han) rat. AhR cDNAs were 
cloned from a CRL:WI(Han) rat with wild-type AhR protein band (Wild-type), or from an an-
imal homozygous for the smaller protein band (Deletion, Insertion). The size of the predicted 
protein is shown in amino acids (aa). Exons 10 and 11 are represented by open rectangles, and 
the splice site between by a “V”. The wild-type gene has an exon junction at 2454bp. The mu-
tant alleles are designated as “Deletion” and “Insertion”, and have a Val497Ala mutation at ami-
no acid 497. The Deletion variant uses an alternative splice site 129bp upstream from the wild-
type splice site, whereas the Insertion variants use alternative splice sites at +29, 126, 129 or 
134 bp from the wild-type splice site. The intron/exon junction of the mutant WI(Han) AhRs is 
mutated. The site of the omitted exon sequence is shown as a light gray box for the Deletion 
mutation, and the extra sequence in exon 10 is shown as a black box for the Insertion mutations.
FIG. 3. Expression of recombinant AhR variants from CRL:WI(Han) rat. A, Wild-type, 
Insertion (Ins) and Deletion (Del) variants of the CRL:WI(Han) AhR were cloned into a vector, 
and transcribed in a reticulocyte lysate system in the presence of [35S]-methionine. The result-
ing products were electrophoresed, and the gel subjected to phosphor imaging. Molecular 
weight markers are shown in kDa (Mr, kDa). B, Wild-type, Insertion (Ins) and Deletion (Del) 
variants of the CRL:WI(Han) AhR were cloned into pFASTBAC1, and then used to make bac-
ulovirus as described in materials and methods. The viruses were used to infect cells, and com-
pared with uninfected cells (Sf9), by SDS-PAGE of 10μg of cytosolic protein, followed by 
western blotting with an AhR-specific antibody. Visualisation was with ECL. The size of mo-
lecular weight markers is shown in kDa (Mr, Kda).
FIG. 4. Saturation ligand-binding analysis of AhR variants. Wild-type, Insertion (Ins) and 
Deletion (Del) variants of the CRL:WI(Han) AhR were cloned into baculovirus as described in 
Fig. 3, and used to prepare cytosol under optimised conditions (see materials and methods). Sat-
uration ligand-binding to TCDD was performed, and the specific binding to TCDD (in nmol/ 26/11/08 Page 19
JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITYmg cytosolic protein) is plotted against the concentration of TCDD in nanoMolar. Experimental 
determinations were performed in triplicate, and results are shown as mean +/- Standard Devi-
ation; where error bars are not visible, the error is less than the size of the symbol. The Wild-
type is shown as a closed circle, the Insertion as an open triangle, and the Deletion mutant as an 
open square. The values for Bmax and Kd for the experimental data shown were determined by 
non-linear curve fitting, and are shown above the graph, as the mean estimate, with 95% confi-
dence interval in square brackets.
FIG. 5. An SNP assay for genotyping AhR variants in CRL:WI(Han) rats. Wild-type 
(closed square) or mutant (open circle) probes, or no template control for wild-type (NTC1, ver-
tical line) or mutant (NTC2, cross), were used for PCR analysis against 40 ng of wild-type (A), 
homozygous mutant (B), or heterozygous mutant (C) CRL:WI(Han) genomic DNA. Both 
probes were present in the same reaction. Cycle number is shown on the X-axis, and the increase 
in fluorescence in that cycle is shown on the Y-axis. D, a panel of ~90 DNA samples was ana-
lysed by real time PCR for the wild-type and mutant allele. The change in fluorescence for the 
terminal reaction cycle is shown for the wild-type allele on the X-axis, and for the mutant allele 
on the Y-axis. Wild-type samples (+/+) are shown as a closed circle, mutant samples (mut/mut) 
as an open circle, and heterozygous samples (+/mutant) as a half-filled circle. No template con-
trol is shown by a cross.26/11/08 Page 20
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TABLE 1: Oligonucleotide sequences 
Oligonucleotide 
name Oligonucleotide sequence
Fragment 1 forward ATGGCCAGCCGCAAGCGGCGC
Fragment 1 reverse GCAAGGGATCCATTATGGGAGAGAAAGG
Fragment 2 forward CTGGAGAGGCTGTACTGTACGAGAT
Fragment 2 reverse TGCTGCTGCTGAAGCTGC
Fragment 3 forward TGAATTCAGCTTGCCAGCA














Sequence of oligonucleotides used in this study. The designation of the 
oligonucleotide is shown together with the corresponding sequence. HEX (6-
Hexachloro-Fluorescein-CE Phosphoramidite) and FAM (6-carboxyfluorescein) 
represent the 5’ fluorescent groups, and the BHQ1/2 groups at the 3’ end are 
“Black Hole Quencher” moieties.26/11/08 Page 21
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Wild-type Heterozygous Mutant Ratio
P0 acute (124) 27 73 24 1:2.7:0.86
F1 acute (200) 48 98 54 1:2.04:1.13
P0 chronic (78) 26 38 14 1:1.48:0.55
F1 chronic (200) 76 87 37 1:1.16:0.5
CRL:WI(Han) (30) 8 17 5 1:2.11:0.63
CRL:WI (51) 26 24 1 1:0.92:0.039
Tissue samples were analysed by PCR for the presence of wild-type, homozygous 
mutant or heterozygous mutant alleles, as described in Fig. 5. Animal samples were 
parental GD16 or 21 kills (P0) or offspring (F1) from the acute dose (Bell et al., 
2007b) (Acute) or chronic dose (Bell et al., 2007c) (Chronic) studies. The total 
number of animals is indicated in brackets. Thirty non-sibling CRL:WI(Han) were 
obtained from Charles River for a sampling of the stock, and CRL:WI animals 
were of unknown sibling status were obtained over a period of months, prior to 
analysis. The number of wild-type, heterozygous or homozygous mutant animals 
are shown, and this is shown as a ratio in the right-most column, with the wild-type 
ratio set as one.26/11/08 Page 22
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There is no significant effect of genotype on survival probabilities, and no interaction with dose 







TABLE 1: Balano-preputial separation. The dose-response relationship for effects on bal-
ano-preputial separation was examined using ANOVA methods, using mixed models with a 
random term for litter effects; these responses were analysed, for those animals and tissues for 
which genotyping had been carried out, under the same models but with an additional factor rep-
resenting the genotype as wild type, mutant or heterozygous. Group indicates TCDD treatment 
group, Type indicates genotype, and Group.Type indicates an interaction between Group and 
genotype. 
Term p-value
F1 CYP1A1 RNA Maternal CYP1A1 RNA
Acute Chronic Acute Chronic
Group <0.001 <0.001 <0.001 <0.001
Type 0.019 0.739 0.073 0.984
Group.Type 0.368 0.64 0.905 0.819
TABLE 2: CYP1A1 RNA levels.  The dose-response relationship for effects on CYP1A1 
RNA levels was examined using ANOVA methods, using mixed models with a random term 
for litter effects; these responses were analysed, for those animals and tissues for which geno-
typing had been carried out, under the same models but with an additional factor representing 
the genotype as wild type, mutant or heterozygous. Group indicates TCDD treatment group, 
Type indicates genotype, and Group.Type indicates an interaction between Group and geno-
type. 19/11/08 Supplementary Material Page 1
JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITYThere is a significant effect of dose group, and no significant interaction of genotype with dose 
group in all four samples. The effect of genotype is not significant in the Chronic F1, or the ma-
ternal liver in either study; however, there is a significant effect of genotype in the Acute study 
F1 samples. The heterozygotes show a 1.7-fold increase in CYP1A1 RNA level over wild-type, 
and the mutants show a 2.5-fold increase. This is discussed further in the results text.
There is no significant effect of group, or genotype, on maternal liver weight in either the Acute 
or Chronic study. The interaction between Group and Genotype is not significant in the chronic 







TABLE 3: Maternal liver weight. The dose-response relationship for effects on maternal liv-
er weight was examined using ANOVA methods, using mixed models with a random term for 
litter effects; these responses were analysed, for those animals and tissues for which genotyping 
had been carried out, under the same models but with an additional factor representing the gen-
otype as wild type, mutant or heterozygous. Group indicates TCDD treatment group, Type in-
dicates genotype, and Group.Type indicates an interaction between Group and genotype. 
Genotype
Group Wild-type Heterozygous Mutant
1 11.63 10.64 11.72
2 10.42 11.66 9.58
3 9.49 11.17 12.86
4 12.77 10.63 12.55
TABLE 4: Predictions of maternal liver weight from regression model. The regression 
model predictions for liver weight with genotype are shown for the acute study data.19/11/08 Supplementary Material Page 2
JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITYHence, although the interaction between group and genotype for maternal liver weight is statis-
tically significant, including genotype as a predictor in the model  shows that there is no con-
sistent or biologically plausible effect of genotype upon response to dioxin.
There is a significant effect of group, genotype and group-genotype interaction in the acute 
study at 10 weeks, but not at 17 weeks, nor in the chronic study.
Bodyweight (log scale)
Kill Term Acute Chronic
10 weeks Group <0.001 0.231
Type 0.027 0.301
Group.Type 0.005 0.581
17 weeks Group 0.287 0.369
Type 0.747 0.376
Group.Type 0.864 0.451
TABLE 5: F1 bodyweights. The dose-response relationship for effects on F1 terminal body 
weight was examined using ANOVA methods, using mixed models with a random term for lit-
ter effects; these responses were analysed, for those animals and tissues for which genotyping 
had been carried out, under the same models but with an additional factor representing the gen-
otype as wild type, mutant or heterozygous. Group indicates TCDD treatment group, Type in-
dicates genotype, and Group.Type indicates an interaction between Group and genotype.19/11/08 Supplementary Material Page 3
JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITY 
There is no significant effect of group, genotype or group-genotype interaction on liver: body-
weight ratios in the F1 animals in either study.
F1 liver: bodyweight ratio
Kill Term Acute Chronic
10 weeks Group 0.737 0.323
Type 0.218 0.988
Group.Type 0.362 0.669
17 weeks Group 0.185 0.252
Type 0.778 0.286
Group.Type 0.638 0.524
TABLE 6: F1 liver: bodyweight ratio. The dose-response relationship for effects on F1 liver: 
body weight ratio was examined using ANOVA methods, using mixed models with a random 
term for litter effects; these responses were analysed, for those animals and tissues for which 
genotyping had been carried out, under the same models but with an additional factor represent-
ing the genotype as wild type, mutant or heterozygous. Group indicates TCDD treatment group, 
Type indicates genotype, and Group.Type indicates an interaction between Group and geno-
type.19/11/08 Supplementary Material Page 4
JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITYThere was a significant effect of dose group, and genotype, in the chronic study at the 10 week 
kill, but not at 17 weeks, and there were no significant effects in the acute study on these param-
eters.
Spleen: bodyweight ratio
Kill Term Acute Chronic
10 weeks Group 0.212 0.025
Type 0.813 0.015
Group.Type 0.311 0.603
17 weeks Group 0.593 0.107
Type 0.571 0.132
Group.Type 0.360 0.663
TABLE 7: F1 spleen: bodyweight ratio. The dose-response relationship for effects on F1 
spleen: body weight ratio was examined using ANOVA methods, using mixed models with a 
random term for litter effects; these responses were analysed, for those animals and tissues for 
which genotyping had been carried out, under the same models but with an additional factor rep-
resenting the genotype as wild type, mutant or heterozygous. Group indicates TCDD treatment 
group, Type indicates genotype, and Group.Type indicates an interaction between Group and 
genotype.19/11/08 Supplementary Material Page 5
JIANG ET AL. THE WISTAR(HAN) AHR AND TOXICITYThere are multiple significant effects of PND, Group and genotype in both studies, and interac-
tions between these variables. To determine if these effects were likely to be plausible, the dif-
ference between the weight of the wild-type group, and the homozygous (supplementary Figure 
1) or heterozygous (Supplementary Figure 2) mutants was plotted for each dose group as a func-
tion of post-natal day for each study. Supplementary Figure 2 shows absolutely no biologically 
plausible relationship between dose group, genotype, and post-natal day; moreover, the magni-
tude of changes is from +20g to -30g. Supplementary Figure 1 also shows changes within this 
range of values, and it is noticeable that the acute and chronic control groups are the most widely 
separated values in this analysis. There is therefore no plausible relationship between the geno-
type, and with serial body weight.









TABLE 8: F1 serial body weights. he dose-response relationship for effects on F1 serial body 
weights was examined using ANOVA methods, using mixed models with a random term for 
litter effects; these responses were analysed, for those animals and tissues for which genotyping 
had been carried out, under the same models but with an additional factor representing the gen-
otype as wild type, mutant or heterozygous. Group indicates TCDD treatment group, Type in-
dicates genotype, and Group.Type indicates an interaction between Group and genotype.19/11/08 Supplementary Material Page 6


